JO2637B1 - Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels - Google Patents

Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels

Info

Publication number
JO2637B1
JO2637B1 JO2006475A JOP20060475A JO2637B1 JO 2637 B1 JO2637 B1 JO 2637B1 JO 2006475 A JO2006475 A JO 2006475A JO P20060475 A JOP20060475 A JO P20060475A JO 2637 B1 JO2637 B1 JO 2637B1
Authority
JO
Jordan
Prior art keywords
lowering
benzo
fused heterocycle
blood glucose
glucose levels
Prior art date
Application number
JO2006475A
Other languages
Arabic (ar)
Inventor
ال .سميث - سوينتوسكي فيرجينيا
بي. ريتز الين
Original Assignee
جانسن فارمسيتكا ان في
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by جانسن فارمسيتكا ان في filed Critical جانسن فارمسيتكا ان في
Application granted granted Critical
Publication of JO2637B1 publication Critical patent/JO2637B1/en

Links

Abstract

The present invention is a method for the glucose related disorders and lipid related disorders comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) or formula(II) as herein defined, the present invention is further directed to methods of treatment comprising co-therapy with an anti-diabetic agent, and anti-lipid agent and or an anti-obesity agent
JO2006475A 2005-12-19 2006-12-19 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels JO2637B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75167705P 2005-12-19 2005-12-19

Publications (1)

Publication Number Publication Date
JO2637B1 true JO2637B1 (en) 2012-06-17

Family

ID=38813247

Family Applications (1)

Application Number Title Priority Date Filing Date
JO2006475A JO2637B1 (en) 2005-12-19 2006-12-19 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels

Country Status (6)

Country Link
AR (1) AR058390A1 (en)
ES (1) ES2353978T3 (en)
JO (1) JO2637B1 (en)
TW (1) TW200744579A (en)
UA (1) UA94077C2 (en)
UY (1) UY30036A1 (en)

Also Published As

Publication number Publication date
AR058390A1 (en) 2008-01-30
UY30036A1 (en) 2007-03-30
ES2353978T3 (en) 2011-03-08
UA94077C2 (en) 2011-04-11
TW200744579A (en) 2007-12-16

Similar Documents

Publication Publication Date Title
HK1125287A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
MY150903A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
NZ600000A (en) Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions
HK1141231A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
WO2007095615A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain
IL192103A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
WO2007095609A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder
JO2637B1 (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
AR059496A1 (en) USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES TO DECREASE LIPIDS AND DECREASE GLUCOSE LEVELS IN BLOOD
UA94079C2 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
UA100552C2 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety and related disorders
JO2586B1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
UA95094C2 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
UA97106C2 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
UA92208C2 (en) method for treatment of diabetic angioneuroretinopathy
JO2608B1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression